Walleye Trading’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Walleye Trading’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19,801	Closed	-$669K	–	6117
2021 Q2	$669K	Buy	19,801 +18,052	+1,032%	+$460K	﹤0.01%	2572
2021 Q1	$41K	Buy	+1,749	New	+$53K	﹤0.01%	4394
2020 Q2	–	Sell	-322	Closed	-$11.6K	–	4775
2020 Q1	$10K	Buy	+322	New	+$11.2K	﹤0.01%	3730

Walleye Trading's CNST Position: Q3 2021 in Review

Walleye Trading sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 19,801 shares — an estimated $669K sold.

Walleye Trading first reported a position in CNST in Q1 2020 and held it in 3 quarters. The position peaked at $669K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Walleye Trading reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Walleye Trading sold 19,801 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $669K.
Walleye Trading first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 3 quarters.
Walleye Trading's Constellation Pharmaceuticals, Inc. position peaked at $669K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Walleye Trading's 13F filing for Q3 2021, filed 15 Nov 2021.